CSL - Ebit

Stock Price
141.36
Daily Change
0.70 0.50%
Monthly
-7.45%
Yearly
-42.93%
Q1 Forecast
138.07

CSL reported $2.64B in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Arca Biopharma USD -25.09M 5.23M Mar/2025
aTyr Pharma USD -226.49K 140.85K Sep/2025
Bio Path USD -3.24M 616K Mar/2025
Brainstorm Cell Therapeutics USD -3.09M 100K Mar/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
CSL USD 2.64B 116M Dec/2025
Curis USD -12.37M 230K Sep/2023
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Immunic USD -22.81M 756K Jun/2024
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
TherapeuticsMD USD -1.77M 699K Sep/2023